Product
QA102/Placebo
1 clinical trial
1 indication
Indication
Age-related Macular DegenerationClinical trial
A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of QA102 in Subjects With Dry Age-Related Macular Degeneration (AMD)Status: Active (not recruiting), Estimated PCD: 2025-01-01